Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Peanuts and stress: does eating peanuts affect heart health markers in people under high stress

Official title: Effects of Peanut Consumption on Physiological and Psychosocial Stress, Circulating Immune Cell Status, Markers of Inflammation and Cardiovascular Disease Risk, and Gastrointestinal Health in High-Stress Individuals

Run by USDA, Western Human Nutrition Research Center · NCT07735221 · Data updated 2026-11-12

This study tests whether adding roasted peanuts to the diet can improve immune and cardiovascular risk markers in adults who report high chronic stress.

More Cardiovascular Health trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment70 (estimated)
SponsorUSDA, Western Human Nutrition Research Center
Federal
Locations1 site (Davis, California)
StatusRecruiting
StartedSeptember 2026
Main results expectedAugust 2028
Study endsAugust 2028
Registry record updatedSeptember 11, 2026
Trial IDNCT07735221 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with BMI 18.5–39.9 kg/m2 and a high perceived stress score who do not have major nut allergies or conflicting medications.

Probably not a fit

Individuals with preexisting severe nut allergies or who do not respond to dietary peanut exposure related to their baseline health status may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates whether daily consumption of roasted, salted peanuts with skins influences indicators of cardiovascular disease risk in adults experiencing high perceived stress. Nut consumption is the dietary exposure, with isocaloric foods used to help isolate effects on immune function, inflammation, and vascular health. Eligible participants are adults aged 18–65 with BMI 18.5–39.9 kg/m2 and a confirmed high stress level by the PSS-4. The study aims to understand if peanut intake can modulate stress-related physiological pathways, including SNS and HPA axis activity, and thereby impact CVD risk markers. No results are provided here; the trial protocol outlines procedures to monitor safety and collect relevant biomarkers over the intervention period.

Why it matters

Potential benefit: If successful, participants could experience improvements in cardiovascular risk markers associated with chronic stress.

How similar studies have gone: Previous nutrition studies suggest that certain nuts can favorably influence inflammation and cardiovascular markers, though results vary by context and population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males and females
* 18-65 years old
* BMI ≥ 18.5 kg/m2 and ≤ 39.9 kg/ m2
* Recruitment will be based on Perceived Stress Scale - 4 (PSS-4) score

Exclusion Criteria:

* Less than 18 and over 65 years old
* Pregnant or lactating women
* Adults who rely on prescription medication that may influence study variables, apart from birth control
* BMI \< 18.5 kg/m2 and \> 39.9 kg/m2
* Smokers who currently use tobacco- or marijuana-containing products including e-cigarettes, vape pens, pod mods, tanks, and electronic nicotine delivery devices (ENDS)
* Habitual consumption of nuts, nut butters, nut powders, nut side dishes, nut bars or other nut products
* Known food allergies (milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, sesame, corn) due to samples not prepared in a hypoallergenic environment
* Currently living in close contact with individuals who have an allergy to peanuts, in order to avoid exposing these individuals to an allergen
* Self-reported history of difficulties with blood drawing procedures including prior fainting or dizziness, or veins assessed as not suitable for four separate venipunctures by licensed phlebotomist
* Diagnosed active chronic diseases for which the individual is currently taking daily medication, including but not limited to:

  * Diabetes mellitus, cardiovascular disease, cancer, gastrointestinal disorders, kidney disease, liver disease, bleeding disorders, asthma, autoimmune disorders, hypertension, osteoporosis
* Recent minor surgery (within 4 weeks) or major surgery (within 16 weeks)
* Known gallbladder disease or history of cholecystectomy
* History of gastrointestinal surgery, including gastric bypass surgery or resection
* Diagnosis of irritable bowel syndrome
* Recent antibiotic therapy (within 4 weeks)
* Recent hospitalization (within 4 weeks)
* Current participation in another research study
* Has HIV/AIDS, hepatitis, or another disease that affects the immune system
* Gives regular blood donations and is unwilling to stop during the study
* Blood Pressure ≥ 140 mmHg systolic or 90 mmHg diastolic
* Current diagnoses of an eating disorder (ex. anorexia, bulimia, etc.)
* High - very high triglyceride levels: ≥ 300 mg/dL
* Adults who are unable to consent, individuals who are not yet adults (infants, children and teenagers), pregnant women and prisoners will be excluded from participation in the study
* Participants who are unwilling to collect and transport urine, stool and saliva samples
* Abnormal hemoglobin and/or hematocrit levels
* Abnormal liver function (defined as liver enzymes that are \>200% of upper limit (ALT upper limit is 43 U/L or Aspartate transaminase (AST) upper limit is 54 U/L)
* Unwillingness to discontinue probiotic, prebiotic, fiber, or other supplements (except RDA-level vitamin and mineral supplements) during the study
* Unwilling to consume study foods
* Alcohol consumption \> 20 g/day

Where it's running

  • Western Human Nutrition Research Center
    Davis, California, United States
    Recruiting

Study contacts

  • Principal investigator: Ryan Snodgrass, PhD — United States Department of Agriculture - Western Human Nutrition Research Center
  • Study coordinator: Ellen Bonnel, PhD
  • Email: elbonnel@ucdavis.edu
  • Phone: 530-752-4184

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.